Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Rombaut

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Hepatology|May 14, 2021
Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma codeMatthias Rombaut, Joost Boeckmans, Robim M Rodrigues, et al.
Cells|December 28, 2019
Anti-NASH Drug Development Hitches a Lift on PPAR AgonismJoost Boeckmans, Alessandra Natale, Matthias Rombaut, et al.
Biomedicines|January 21, 2022
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical InsightsAlexandra Gatzios, Matthias Rombaut, Karolien Buyl, et al.
Cells|March 10, 2022
Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric SurgeryJoost Boeckmans, Alexandra Gatzios, Anja Heymans, et al.
Methodsx|October 7, 2020
Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASHJoost Boeckmans, Alessandra Natale, Matthias Rombaut, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 8, 2025
Phenylketonuria: A guide through the complex maze of its neurological pathophysiology providing a new perspective on treatment strategiesIne Nulmans, Sien Lequeue, Liesbeth Desmet, et al.
Genes|May 6, 2020
Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5' Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile AnalysisJennifer Bolleyn, Matthias Rombaut, Nisha Nair, et al.
Archives of Toxicology|August 4, 2022
Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the diseaseGigly G Del'haye, Ine Nulmans, Sandrine P Bouteille, et al.
European Journal of Pharmacology|August 10, 2025
A robust bacterial high-throughput screening assay to identify pharmacological chaperones targeting human homogentisate 1,2-dioxygenase missense variants in alkaptonuriaSien Lequeue, Hind Allach, Ine Nulmans, et al.
Cell Biology and Toxicology|July 3, 2020
Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonistsJoost Boeckmans, Alessandra Natale, Matthias Rombaut, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Hepatology|May 14, 2021
Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma codeMatthias Rombaut, Joost Boeckmans, Robim M Rodrigues, et al.
Cells|December 28, 2019
Anti-NASH Drug Development Hitches a Lift on PPAR AgonismJoost Boeckmans, Alessandra Natale, Matthias Rombaut, et al.
Biomedicines|January 21, 2022
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical InsightsAlexandra Gatzios, Matthias Rombaut, Karolien Buyl, et al.
Cells|March 10, 2022
Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric SurgeryJoost Boeckmans, Alexandra Gatzios, Anja Heymans, et al.
Methodsx|October 7, 2020
Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASHJoost Boeckmans, Alessandra Natale, Matthias Rombaut, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 8, 2025
Phenylketonuria: A guide through the complex maze of its neurological pathophysiology providing a new perspective on treatment strategiesIne Nulmans, Sien Lequeue, Liesbeth Desmet, et al.
Genes|May 6, 2020
Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5' Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile AnalysisJennifer Bolleyn, Matthias Rombaut, Nisha Nair, et al.
Archives of Toxicology|August 4, 2022
Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the diseaseGigly G Del'haye, Ine Nulmans, Sandrine P Bouteille, et al.
European Journal of Pharmacology|August 10, 2025
A robust bacterial high-throughput screening assay to identify pharmacological chaperones targeting human homogentisate 1,2-dioxygenase missense variants in alkaptonuriaSien Lequeue, Hind Allach, Ine Nulmans, et al.
Cell Biology and Toxicology|July 3, 2020
Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonistsJoost Boeckmans, Alessandra Natale, Matthias Rombaut, et al.
Pageof 2